Home/Olatec Therapeutics/Damaris B. Skouras

DB

Damaris B. Skouras

Founder, Chairman, Chief Executive Officer

Olatec Therapeutics

Therapeutic Areas

Inflammatory Diseases Arthritis Cardiovascular Neurology Oncology Metabolic Diseases

Olatec Therapeutics Pipeline

Drug	Indication	Phase
Dapansutrile (OLT1177®)	Broad spectrum of NLRP3-mediated inflammatory diseases (e.g., Arthritis, Heart Failure, Neurodegenerative)	Phase 2

Leadership Team at Olatec Therapeutics

Charles A. Dinarello, MD

Chairman of SAB, co-Chief Scientific Officer

View full Olatec Therapeutics profile